Meeting
2015 ASCO Annual Meeting
Role of HE4, CA125, and ultrasound in risk assessment in pelvic mass patients: Results from a prospective, multicentric study.
Authors
Elena Ioana Braicu
Charité– Universitätsmedizin Berlin, Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité Campus Virchow Klinikum, Berlin, Germany
Elena Ioana Braicu , Uwe Torsten , Herbert Mecke , Rolf Richter , Kerstin Ames , Lars Hellmeyer , Kati Hasenbein , Gerhard Nohe , Frank Chen , Carmen Rosa Beteta , Ricarda Isermann , Radoslav Chekerov , Marcelo Bustamante , Anna-Maria Dueckelmann , Miriam Christophi , Mueller Bodo , N. Monetaer , Mathias Zimmermann , Janine Bonness-Zaloum , Jalid Sehouli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 5535)
DOI
10.1200/jco.2015.33.15_suppl.5535
Abstract #
5535
Poster Bd #
93
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
A multivariate longitudinal algorithm for early detection of ovarian cancer using multiple biomarkers.
First Author: Z. Zhang
Poster
2024 ASCO Annual Meeting
Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women.
First Author: Brendan Manning
Poster
2017 ASCO Annual Meeting
Circulating free DNA and circulating tumor cells as new serum biomarkers in advanced ovarian cancer.
First Author: Jeronimo Martinez garcia
Poster
2016 ASCO Annual Meeting
Validation of a multi-marker panel for early detection of ovarian cancer.
First Author: Robert C. Bast Jr.